Elevation Oncology Statistics
Total Valuation
ELEV has a market cap or net worth of $144.25 million. The enterprise value is $71.00 million.
| Market Cap | 144.25M |
| Enterprise Value | 71.00M |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, before market open.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ELEV has 54.64 million shares outstanding. The number of shares has increased by 100.57% in one year.
| Shares Outstanding | 54.64M |
| Shares Change (YoY) | +100.57% |
| Shares Change (QoQ) | +39.01% |
| Owned by Insiders (%) | 0.25% |
| Owned by Institutions (%) | 96.82% |
| Float | 28.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.90 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 46.22, with a Debt / Equity ratio of 0.41.
| Current Ratio | 46.22 |
| Quick Ratio | n/a |
| Debt / Equity | 0.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 342.88 |
Financial Efficiency
Return on equity (ROE) is -59.30% and return on invested capital (ROIC) is -36.17%.
| Return on Equity (ROE) | -59.30% |
| Return on Assets (ROA) | -38.50% |
| Return on Capital (ROIC) | -36.17% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.36M |
| Employee Count | 29 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ELEV has paid $36,000 in taxes.
| Income Tax | 36,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +72.55% in the last 52 weeks. The beta is 1.40, so ELEV's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | +72.55% |
| 50-Day Moving Average | 3.22 |
| 200-Day Moving Average | 2.53 |
| Relative Strength Index (RSI) | 40.36 |
| Average Volume (20 Days) | 1,330,576 |
Short Selling Information
The latest short interest is 5.19 million, so 9.50% of the outstanding shares have been sold short.
| Short Interest | 5.19M |
| Short Previous Month | 5.30M |
| Short % of Shares Out | 9.50% |
| Short % of Float | 18.14% |
| Short Ratio (days to cover) | 6.19 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -38.57M |
| Pretax Income | -39.32M |
| Net Income | -39.35M |
| EBITDA | -39.39M |
| EBIT | -39.43M |
| Earnings Per Share (EPS) | -$0.98 |
Balance Sheet
The company has $104.05 million in cash and $30.81 million in debt, giving a net cash position of $73.24 million or $1.34 per share.
| Cash & Cash Equivalents | 104.05M |
| Total Debt | 30.81M |
| Net Cash | 73.24M |
| Net Cash Per Share | $1.34 |
| Equity (Book Value) | 75.82M |
| Book Value Per Share | 1.39 |
| Working Capital | 105.55M |
Cash Flow
| Operating Cash Flow | -48.92M |
| Capital Expenditures | n/a |
| Free Cash Flow | -48.92M |
| FCF Per Share | -$1.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ELEV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -100.57% |
| Shareholder Yield | -100.57% |
| Earnings Yield | -27.28% |
| FCF Yield | -33.92% |
Analyst Forecast
The average price target for ELEV is $7.80, which is 195.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.80 |
| Price Target Difference | 195.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -17.57% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |